Stock·NYSE·Consumer Cyclical
Abercrombie & Fitch Co. (ANF)
- Market cap
- $6.45B
- P/E
- 13.13
- Dividend yield
- 0.52%
- Street target
- $165.00median of 15 analysts
- 52-week range
- $65.45 $156.72
The short version
Where ANF stands today, in four lines, and what CleaRank Financial AI makes of it.
ANF at a glance
Abercrombie & Fitch Co. (ANF): Hold, 55/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($133.45 and $102.54).
- Earnings ANF beat estimates in 6 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $51.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 13.1 against 20.8 for the Consumer Cyclical sector: a discount to peers (-37%).
Figures as of October 16, 2026.
CleaRank Financial AI
Abercrombie & Fitch Co. (ANF) is currently trading at $153.16, a level that reflects its strong recent performance and positive outlook.
The company has consistently beaten earnings estimates, with the latest quarter showing an EPS surprise of 111.68%. Analysts maintain a generally positive view, with a consensus 'Buy' rating and a median price target of $165.00, implying a 7.7% upside. The stock is trading above its 50-day and 200-day moving averages ($133.45 and $102.54), indicating a bullish trend. However, significant insider selling, totaling $51.5 million in the last reporting period, presents a notable risk. While the company's fundamentals are solid, with a profit margin of 10.04% and a return on equity of 40.61%, the current valuation is approaching sector averages, suggesting limited room for further upside without continued strong execution.
Only on CleaRank
Figures we compute ourselves from ANF's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $153.16 is 14.8% above the 50-day simple moving average of $133.45.Price above its 200-day average ›
The price is 49.4% above the 200-day simple moving average of $102.54.50-day average above the 200-day ›
The 50-day average ($133.45) is 30.1% above the 200-day average ($102.54), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 96% of its 52-week range, between $65.45 and $156.72.
ANF share price
Pick a period: each tab shows how far ANF has moved over it, to the last close.
Today's trading
Where ANF sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 13.13 is 36.9% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 1.21 is 36.4% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $536.0M on revenue of $5.3B, a net margin of 10.0%.Beat estimates in most recent reports ›
ANF beat the EPS estimate in 6 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.52%, or $0.8 a share a year.
Key statistics
The headline figures for ANF.
As of October 16, 2026, ANF trades at $153.16, with a market value of $6.45B, a P/E ratio of 13.13 and a dividend yield of 0.52%.
What the numbers say
CleaRank Financial AI's reading of ANF's valuation, growth and risks.
Abercrombie & Fitch Co. (ANF) presents a mixed fundamental picture.
Its P/E ratio of 13.13 is below the sector average of 20.8, suggesting a potential value proposition, though its price-to-sales ratio of 1.21 is closer to the sector median of 1.9. The company boasts an impressive return on equity of 40.61% and a profit margin of 10.04%, significantly outperforming the sector's ROE of 12.4%. However, its debt-to-equity ratio of 0.94 is in line with the sector average. The strong profitability metrics are attractive, but the current stock price is trading at a premium relative to its historical performance and is nearing sector averages, which could limit further multiple expansion.
ANF against the Consumer Cyclical sector
How ANF compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: ANF trades at a notable discount to sector peers (-37%), which may indicate undervaluation or specific company headwinds.
Return vs XLY: Since May 6, 2025, ANF has gained 120.1% against a gain of 13.3% for XLY.
Performance against XLY
ANF and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much ANF sells, and how much of it becomes profit.
Revenue growth: Revenue grew 6.4% in FY2026 to $5.3B, from $4.9B a year earlier.
Profit margin: The net margin was 9.8% in FY2026, down from 11.6% the year before.
Profitable: ANF earned $515M in FY2026.
Earnings reality check
Did ANF beat what analysts expected, and how did the stock react?
Earnings record: ANF beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 26, 2026after close | $1.97 | $4.17 | +111.68% | -1.35% | -7.55% |
| Mar 4, 2026after close | $3.57 | $3.68 | +3.08% | -7.58% | -8.75% |
| Nov 25, 2025after close | $2.16 | $2.36 | +9.26% | +5.43% | +10.38% |
| Aug 27, 2025after close | $2.30 | $2.91 | +26.52% | +1.22% | -1.97% |
| May 28, 2025after close | $1.33 | $1.59 | +19.55% | -6.14% | -14.06% |
| Mar 5, 2025after close | $3.60 | $3.57 | -0.83% | -4.18% | -12.28% |
| Nov 26, 2024after close | $2.35 | $2.50 | +6.38% | +1.32% | +10.16% |
As of October 16, 2026, ANF has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 26, 2026, came in 111.68% above the estimate and the stock moved -1.35% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 69.5, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 69.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of ANF
The score, the reasoning behind it, and what could move the price next.
Abercrombie & Fitch Co. (ANF) is exhibiting a bullish trend, trading above its 50-day SMA of $133.45 and its 200-day SMA of $102.54.
The 14-day RSI is at 69.48, indicating strong momentum but nearing overbought territory. The MACD is positive at 4.92, further supporting the bullish sentiment. The stock is also trading above its 20-day EMA of $142.74. Key support levels are now established around the moving averages, while resistance may be found near recent highs.
Consistent Earnings Beats ›
Abercrombie & Fitch Co. has a history of exceeding analyst EPS estimates, as demonstrated by the 111.68% surprise in the most recent quarter, indicating strong operational execution.
Source: Company Earnings ReportsPositive Analyst Sentiment ›
The majority of analysts covering Abercrombie & Fitch Co. maintain a 'Buy' or 'Hold' rating, with a median price target of $165.00, suggesting confidence in future performance.
Source: Wall Street Analysts
Heavy Insider Selling ›
Insiders have sold over $51.5 million worth of stock, signaling potential concerns or a need for liquidity among management, which could weigh on the stock price.
Source: Insider Transaction FilingsApproaching Sector Valuation Averages ›
While still showing value, Abercrombie & Fitch Co.'s valuation metrics are nearing sector averages, potentially limiting further multiple expansion and upside.
Source: Company Financials & Sector Data
- Given the stock is trading above its 50-day and 200-day moving averages ($133.45 and $102.54), consider waiting for a pullback to a support level for a more favorable entry point.
- The company's dividend yield is modest at 0.52%, making it less attractive for income-focused investors compared to other opportunities in the Consumer Cyclical sector.
Technical indicators
Momentum and trend for ANF, from its daily closes.
As of October 16, 2026, with ANF at $153.16, its 14-day RSI is 69.5 (showing bullish momentum without being overbought), its 50-day simple moving average is $133.45 and its 200-day is $102.54.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ANF moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, ANF's 1-year correlation of daily returns is +0.33 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.08 with Bitcoin (BTC) and -0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
8 of 15 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $165.00 is 7.7% above the price.More buy ratings than three months ago ›
8 of 15 rate it a buy now, against 8 of 14 three months ago.
ANF Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | BTIG | Reiterates | Buy |
| Sep 9, 2026 | BMO Capital | Initiates | Outperform |
| Aug 31, 2026 | Argus Research | Upgrade | Buy |
| Aug 27, 2026 | Citigroup | Downgrade | Neutral |
| Aug 27, 2026 | Barclays | Maintains | Equal-Weight |
| Aug 27, 2026 | UBS | Maintains | Buy |
As of October 16, 2026, 15 Wall Street analysts cover ANF: 8 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $134.00 to $185.00, with a median of $165.00, 7.7% above the price of $153.16.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ANF trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ANF's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ANF tends to move, against the market and on its own.
The long record
ANF's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.20% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 72.0%, from May 2019 to April 2020, regained by March 2021.Most 1-year holds ended higher ›
57% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $115,110, against $42,525 in the S&P 500 (SPY).
ANF Drawdowns & Recovery
As of October 16, 2026, ANF's worst peak-to-trough fall over the last 10 years with dividends reinvested was -72.0% (May 2019 to April 2020); it regained that peak by March 2021, 11 months after the low, and 57% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ANF in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ANF beat the S&P 500 over this period: $115,110 against $42,525.
A $10,000 investment in ANF in October 2016 would be worth about $115,110 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ANF, and which have not.
Strongest month, November: an average of +19.58%, up in 9 of 10 years.
Weakest month, June: an average of -3.19%, up in 4 of 10 years.
This month, October: has averaged +0.52%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ANF's strongest calendar month has been November (average +19.58%, up in 9 of 10 years) and its weakest June (average -3.19%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ANF, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ANF today could grow to about $28,300 by 2036 in the base case, with a 90th-percentile outcome near $214,704 and a 10th-percentile outcome around $3,730. The simulation models price only; at today's 0.52% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ANF Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $232 for ANF by 2030 in the base case, from $153 today (1.5x over 4 years). The 10th-percentile path ends near $64.45. These are outcomes of a Monte Carlo simulation run on ANF's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $89.54 | $170 | $323 | |
| 2028 | $76.19 | $189 | $467 | |
| 2029 | $68.97 | $209 | $635 | |
| 2030 | $64.45 | $232 | $836 | |
| 2031 | $61.48 | $258 | $1,080 |
Method: a lognormal simulation of ANF's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ANF is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
ANF insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought ANF shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, ANF insiders reported 17 open-market sales worth $51.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Scott D Lipesky
Chief Operating Officer
|
Sell | 2.0K | $293.6K |
| Aug 28, 2026 | Gregory J Henchel
Officer
|
Sell | 30.0K | $4.4M |
| Aug 28, 2026 | Scott D Lipesky
Officer
|
Sell | 5.0K | $745.0K |
| Aug 28, 2026 | Jay Rust
Officer
|
Sell | 5.0K | $737.5K |
| Aug 28, 2026 | Kenneth B. Robinson
Director
|
Sell | 800 | $119.8K |
| Aug 10, 2026 | Scott D Lipesky
Chief Operating Officer
|
Sell | 10.0K | $1.2M |
| Aug 4, 2026 | Scott D Lipesky
Chief Operating Officer
|
Sell | 10.0K | $1.1M |
| Jul 28, 2026 | Scott D Lipesky
Chief Operating Officer
|
Sell | 10.0K | $1.1M |
| Jul 16, 2026 | Scott D Lipesky
Chief Operating Officer
|
Sell | 10.0K | $1.0M |
| Jun 3, 2026 | Kerrii B Anderson
Director
|
Grant | 1.6K | - |
| Jun 3, 2026 | Andrew Paul Clarke
Director
|
Option | 2.1K | $159.6K |
| Jun 3, 2026 | Suzanne M Coulter
Director
|
Option | 2.1K | $159.6K |
| Jun 3, 2026 | James A Goldman
Director
|
Grant | 2.1K | - |
| Jun 3, 2026 | Fran Horowitz
Chief Executive Officer
|
Grant | 25.0K | - |
| Jun 3, 2026 | Helen E. Mccluskey
Director
|
Grant | 2.1K | - |
| Jun 3, 2026 | Arturo Nunez
Director
|
Grant | 2.1K | - |
| Jun 3, 2026 | Kenneth B. Robinson
Director
|
Grant | 2.1K | - |
| Jun 3, 2026 | Nigel Travis
Director
|
Grant | 3.4K | - |
| Jun 3, 2026 | Helen Vaid
Director
|
Grant | 2.1K | - |
| Mar 26, 2026 | Samir Desai
Chief Technology Officer
|
Grant | 70.5K | - |
| Mar 26, 2026 | Gregory J Henchel
General Counsel
|
Grant | 24.7K | - |
| Mar 26, 2026 | Fran Horowitz
Chief Executive Officer
|
Grant | 290.9K | - |
| Mar 26, 2026 | Scott D Lipesky
Chief Operating Officer
|
Grant | 70.5K | - |
| Mar 26, 2026 | Jay Rust
Officer
|
Grant | 17.6K | - |
| Mar 23, 2026 | Robert J Ball
Chief Financial Officer
|
Grant | 780 | - |
| Mar 23, 2026 | Joseph Frericks
Officer
|
Grant | 780 | - |
| Mar 23, 2026 | Jay Rust
Officer
|
Grant | 1.9K | - |
| Mar 12, 2026 | Robert J Ball
Chief Financial Officer
|
Grant | 519 | - |
| Mar 12, 2026 | Samir Desai
Chief Technology Officer
|
Grant | 2.4K | - |
| Mar 12, 2026 | Joseph Frericks
Officer
|
Grant | 291 | - |
| Mar 12, 2026 | Gregory J Henchel
General Counsel
|
Grant | 1.2K | - |
| Mar 12, 2026 | Fran Horowitz
Chief Executive Officer
|
Grant | 13.2K | - |
| Mar 12, 2026 | Scott D Lipesky
Chief Operating Officer
|
Grant | 3.5K | - |
| Mar 12, 2026 | Jay Rust
Officer
|
Grant | 1.0K | - |
| Mar 11, 2026 | Robert J Ball
Chief Financial Officer
|
Grant | 1.6K | - |
| Mar 11, 2026 | Samir Desai
Chief Technology Officer
|
Grant | 3.9K | - |
| Mar 11, 2026 | Joseph Frericks
Officer
|
Grant | 715 | - |
| Mar 11, 2026 | Gregory J Henchel
General Counsel
|
Grant | 2.0K | - |
| Mar 11, 2026 | Fran Horowitz
Chief Executive Officer
|
Grant | 21.8K | - |
| Mar 11, 2026 | Scott D Lipesky
Chief Operating Officer
|
Grant | 5.7K | - |
| Mar 11, 2026 | Jay Rust
Officer
|
Grant | 1.8K | - |
| Mar 9, 2026 | Robert J Ball
Chief Financial Officer
|
Grant | 1.2K | - |
| Mar 9, 2026 | Samir Desai
Officer
|
Grant | 11.8K | - |
| Mar 9, 2026 | Joseph Frericks
Officer
|
Grant | 1.2K | - |
| Mar 9, 2026 | Gregory J Henchel
General Counsel
|
Grant | 4.1K | - |
| Mar 9, 2026 | Fran Horowitz
Chief Executive Officer
|
Grant | 48.5K | - |
| Mar 9, 2026 | Scott D Lipesky
Chief Operating Officer
|
Grant | 11.8K | - |
| Mar 9, 2026 | Jay Rust
Officer
|
Grant | 2.9K | - |
| Feb 6, 2026 | Fran Horowitz
Chief Executive Officer
|
Sell | 29.8K | $3.0M |
| Feb 5, 2026 | Fran Horowitz
Chief Executive Officer
|
Sell | 67.0K | $6.9M |
| Feb 3, 2026 | Fran Horowitz
Chief Executive Officer
|
Sell | 100.0K | $10.1M |
| Jan 23, 2026 | Fran Horowitz
Chief Executive Officer
|
Sell | 203.2K | $19.7M |
| Sep 5, 2025 | Kenneth B. Robinson
Director
|
Sell | 1.4K | $131.7K |
| Aug 29, 2025 | James A Goldman
Director
|
Sell | 5.1K | $487.8K |
| Aug 29, 2025 | Kerrii B Anderson
Director
|
Sell | 4.3K | $408.2K |
| Aug 29, 2025 | Jay Rust
Officer
|
Sell | 1.5K | $139.7K |
| Jul 15, 2025 | Robert J Ball
Chief Financial Officer
|
Grant | 2.0K | - |
| Jun 11, 2025 | Kerrii B Anderson
Director
|
Grant | 780 | - |
| Jun 11, 2025 | Suzanne M Coulter
Director
|
Option | 780 | $61.6K |
| Jun 11, 2025 | James A Goldman
Director
|
Grant | 780 | - |
| Jun 11, 2025 | Helen E. Mccluskey
Director
|
Grant | 780 | - |
| Jun 11, 2025 | Arturo Nunez
Director
|
Grant | 780 | - |
| Jun 11, 2025 | Kenneth B. Robinson
Director
|
Option | 780 | $61.6K |
| Jun 11, 2025 | Nigel Travis
Director
|
Grant | 1.3K | - |
| Jun 11, 2025 | Helen Vaid
Director
|
Grant | 780 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.